Figure 4 Fluorescent imaging of gastric cancer-bearing nude mouse via tail vein injection with HAI-178-FMNPs by animal imaging system. (A) Nude mouse loaded with gastric cancer. (B) Fluorescent imaging of the tumor site. (C) Overlay picture of gastric cancer-bearing nude mouse and fluorescent imaging of the tumor site. Nanoprobes for MR imaging of gastric
cancer-bearing nude mice In vivo MR imaging was performed on nude mice loaded with subcutaneous gastric cancer at 12 h post-injection. Representative selleck images of T2 maps were shown in Figure 5. Figure 5A showed MR image of the nude mouse loaded with gastric cancer at longitudinal section, with circle showing the tumor site; a significant change in signal intensity was observed in site of tumor, indicating that there existed accumulation of the nanoprobes in the tumor site as shown in Figure 5B, showing the MR image of nude mouse at transverse direction. Our result showed that prepared nanoprobes can be used for targeted MR imaging of in vivo gastric cancer. Figure 5 MRI image of gastric cancer-bearing nude mouse. (A) MRI image of nude mouse at longitudinal direction; circle shows tumor site. (B) MRI image of nude mice at horizontal direction; circle shows the tumor
site. Nec-1s mw Nanoprobes for therapy of gastric cancer-bearing nude mice As shown in Figure 6, the tumor tissues in MGCD0103 in vitro control group (treated with saline) grew very quick, and the relative tumor volume became bigger and bigger as the feeding day increased. Molecular motor In the test group treated with FMNPs, under external alternating magnetic field with 63 kHz and 7 kA/m for 4 min, the tumor tissues in gastric cancer-bearing mice grew slower than the mice in control group. In the test group treated with HAI-178 antibody, the tumor tissues grew slower, which highly showed that HAI-178 could inhibit the growth of gastric cancer in vivo, similar to the inhibition of growth of breast cancer in vivo. In test
group HAI-178-FMNPs, the tumor tissues grew slowest, which highly indicate that the prepared HAI-178-FMNPs have a therapeutic function for gastric cancer in vivo. Compared with the control group, a statistical difference existed between two groups (P < 0.05). Our results showed that the prepared HAI-178-conjugated FMNPs have a therapeutic function. Figure 6 Relative tumor volume of nude mice under different treated condition. Pathological analysis of important organs As shown in Figure 7, we used HE staining to check important organs including the heart, liver, spleen, lung and kidney, and no obvious damages were observed, which indirectly suggest that the prepared HAI-178-FMNPs nanoprobes did not damage important organs, showing good biocompatibility. Figure 7 HE staining of important organs such as the heart, liver, spleen, kidney, and lung.